Decheng Capital Global Life Sciences Fund IV, L.P. - 10%+ Owner at Aardvark Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Issuer Symbol
AARD on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Decheng Capital Global Life Sciences Fund IV, L.P. since 11 Mar 2025

Holdings reported by Decheng Capital Global Life Sciences Fund IV, L.P. for Aardvark Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2,958,887 14 Feb 2025 By Decheng Capital Global Life Sciences Fund IV, L.P.
Common Stock 958,412 14 Feb 2025 By Decheng Capital Global Healthcare Fund (Master), LP
Series C Convertible Preferred Stock 0 14 Feb 2025 By Decheng Capital Global Healthcare Fund (Master), LP Common Stock
Series C Convertible Preferred Stock 0 14 Feb 2025 By Decheng Capital Global Life Sciences Fund IV, L.P. Common Stock

Transactions reported by Decheng Capital Global Life Sciences Fund IV, L.P. for Aardvark Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.